+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 178 Pages
  • Global
From
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
Urology Devices Market Report 2025 - Product Thumbnail Image

Urology Devices Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Menopausal Disorders (MD) - Competitive Landscape - Product Thumbnail Image

Menopausal Disorders (MD) - Competitive Landscape

  • Report
  • November 2023
  • 75 Pages
  • Global
From
Pompe Disease Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Pompe Disease Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
Loading Indicator